Table 2.
Baseline characteristics of study subjects
| Study | Age, y | Male ratio, % | Body mass index, kg/m2 | Duration of treatment, y | ||||
|---|---|---|---|---|---|---|---|---|
| RS2 | Control | RS2 | Control | RS2 | Control | RS2 | Controls | |
| Sirich 2014 19 | 54.0 ± 14.0 | 58.0 ± 13.0 | 55.0 | 65.0 | 29.0 ± 7.0 | 29.0 ± 6.0 | 5.0 (2.0, 6.0) | 3.0 (2.0, 6.0) |
| Esgalhado 2018 22 | 56.0 ± 7.5 | 53.5 ± 11.5 | 46.7 | 68.8 | 26.2 ± 5.0 | 26.6 ± 5.3 | 4.2 ± 3.1 | 3.7 ± 2.2 |
| Khosroshahi 2018 20 | 52.0 ± 11.0 | 60.0 ± 14.0 | 54.5 | 72.7 | 23.8 ± 2.4 | 23.3 ± 1.7 | 5.1 ± 1.3 | 4.8 ± 1.8 |
| Khosroshahi 2019 21 | 53.2 ± 10.2 | 57.9 ± 13.3 | 56.0 | 60.0 | 24.4 ± 2.2 | 23.9 ± 1.6 | 5.1 ± 1.3 | 4.8 ± 1.8 |
| Laffin 2019 23 | 53.8 ± 11.8 | 57.6 ± 9.0 | 66.7 | 63.6 | NR | NR | NR | NR |
Note: Data are presented as the mean ± SD or median (25th percentile, 75th percentile). RS2, resistant starch type 2; NR, not reported.